Phreesia, Inc.

PHR

US71944F1066

Software

Market Closed - Nyse Other stock markets 01:30:02 25/05/2024 am IST			5-day change	1st Jan Change
22.63 ^USD	+0.76%		-6.91%	-2.25%

25/03	Phreesia Insider Sold Shares Worth $610,684, According to a Recent SEC Filing	MT
21/03	JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating	MT

Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

March 31, 2022 at 01:32 am IST

Phreesia, Inc. provided earnings guidance for the fiscal year ending January 31, 2023. For the full fiscal year 2023, ending January 31, 2023, the company expected revenue to be between $271 million and $275 million, implying year-over-year growth of 27% to 29%.

Latest news about Phreesia, Inc.

Phreesia Insider Sold Shares Worth $610,684, According to a Recent SEC Filing	26/03	MT
JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating	21/03	MT
Phreesia Names Jack Callahan as Chief Technology Officer	19/03	MT
Phreesia Appoints Jack Callahan as Chief Technology Officer	19/03	CI
Baird Adjusts Price Target on Phreesia to $31 From $30, Maintains Outperform Rating	18/03	MT
Raymond James Raises Phreesia's Price Target to $30 From $25, Maintains Outperform Rating	15/03	MT
Canaccord Genuity Adjusts Price Target on Phreesia to $37 From $36, Maintains Buy Rating	15/03	MT
RBC Raises Price Target on Phreesia to $23 From $17, Cites 'Encouraging Progress Toward Profitability,' Keeps Sector Perform Rating	15/03	MT
Transcript : Phreesia, Inc., Q4 2024 Earnings Call, Mar 14, 2024	15/03
Phreesia Fiscal Q4 Net Loss Narrows, Revenue Increases; FY 2025 Revenue Outlook Maintained; Shares Rise After Hours	15/03	MT
Phreesia Guides For FY 2025 Revenue of $424-$434 Million, vs CIQ Analyst Consensus of $428 Million	15/03	MT
Earnings Flash (PHR) PHREESIA Posts Q4 Revenue $95M, vs. Street Est of $93.5M	15/03	MT
Phreesia, Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024	15/03	CI
Phreesia, Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	15/03	CI
Truist Securities Initiates Phreesia at Buy Rating With $35 Price Target	26/02	MT
Phreesia Insider Sold Shares Worth $1,630,138, According to a Recent SEC Filing	19/01	MT
Phreesia Insider Sold Shares Worth $1,046,093, According to a Recent SEC Filing	19/01	MT
Phreesia Insider Sold Shares Worth $796,441, According to a Recent SEC Filing	19/01	MT
Phreesia Insider Sold Shares Worth $458,552, According to a Recent SEC Filing	19/01	MT
Phreesia Insider Sold Shares Worth $264,468, According to a Recent SEC Filing	19/01	MT
Transcript : Phreesia, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09:45 AM	08/01
Barclays Starts Phreesia With Overweight Rating, $29 Price Target	03/01	MT
KeyBanc Adjusts Phreesia's PT to $30 From $40, Maintains Overweight Rating	07/12	MT
Raymond James Adjusts Price Target on Phreesia to $25 From $30, Keeps Outperform Rating	07/12	MT
Phreesia Shares Jump After Better-Than-Expected Fiscal Q3 Results	06/12	MT

Chart Phreesia, Inc.

Duration

Period

More charts

Company Profile

Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

Sector

Software

Calendar

31/05/2024 - Q1 2025 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Phreesia, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.63 USD

Average target price

30.12 USD

Spread / Average Target

+33.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
PHREESIA, INC.	-2.25%	1.3B
MICROSOFT CORPORATION	+14.39%	3,197B
SYNOPSYS INC.	+14.08%	89.6B
CADENCE DESIGN SYSTEMS, INC.	+8.04%	80.08B
DASSAULT SYSTÈMES SE	-12.11%	55.52B
PALANTIR TECHNOLOGIES INC.	+22.36%	46.79B
ATLASSIAN CORPORATION	-29.01%	43.95B
THE TRADE DESK, INC.	+31.67%	46.34B
SEA LIMITED	+77.73%	41.34B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-3.95%	26.5B

Other Software

Phreesia, Inc.

Equities

PHR

US71944F1066

Software

Phreesia, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

EPS Revisions